Information Library

Results for: Hear From the Experts - Oncology

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Harish Dave Discusses ASH 2011

    December 8, 2011
    Harish Dave discusses the American Society of Hematology annual meeting.

  • Dr. Frank Massam

    May 13, 2011
    Dr. Frank Massam discusses the significance of Quintiles' partnership with Population Genetics Technologies Ltd.

  • Quintiles Joins the I-SPY 2 Breast Cancer Trial

    April 14, 2011
    The I-SPY 2 clinical trial involves 800 patients with advanced breast cancer, and employs innovative adaptive trial design and genetic and biological markers from individual patients’ tumors to screen multiple investigational therapies simultaneously.

  • Exclusive Report From Scientific American

    November 9, 2010
    In-depth insights on every angle of the changing health landscape - brought to you by Quintiles Get the report today.

  • Podcast: Clinical Development of Cancer Drugs in China

    October 18, 2010
    Hear exclusive interviews with Quintiles's experts, Christopher Ung, Patty James and Harish Dave on their recent participation at the 13th Annual Chinese Society of Clinical Oncology

  • The Evolution of Oncologic Drug Development

    July 8, 2010
    Despite a doubling in the number of candidates in the cancer drug pipeline from 1990 through 2006, the overall US approval rate for cancer drugs

  • Mapping the Future in Oncology Drug Development

    March 29, 2010
    A world-renowned, multidisciplinary panel of experts to investigate challenges in, and propose strategies to enhance, oncology drug development.

  • Podcast: Changing the Face of Cancer Research

    August 31, 2009
    Christopher Ung, Vice President, Strategic Business & Operations, Oncology, Quintiles, explains how advances in biomarker technology are ushering in a new era of cancer therapy development.

  • Podcast: Changing the Face of Cancer Research

    August 31, 2009
    Christopher Ung, Vice President, Strategic Business & Operations, Oncology, Quintiles, explains how advances in biomarker technology are ushering in a new era of cancer therapy development.

Page 1 of 1 (9 results)

Subscribe to Email Based on Your Interests

Set preferences